Extranodal Nk T-cell Lymphoma Nasal Type
📧 Sign up to get email alerts when something new happens for Extranodal Nk T-cell Lymphoma Nasal Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma [NA]
A clinical trial update on a three-drug combination (Sintilimab, Chidamide, and Azacitidine) for untreated Stage I–II Extranodal NK/T-cell l…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type [Phase 2]
Phase 2 study evaluating pembrolizumab in patients with early-stage extranodal NK/T-cell lymphoma, nasal type (nasal cavity or nasopharynx);…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma [Phase 3]
A Phase 3 trial comparing MESA versus ESA for early-stage Extranodal NK/T-cell Lymphoma, Nasal Type; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL [Phase 2]
Phase 2 clinical trial evaluating an anti-PD-1 antibody and pegaspargase with radiotherapy for early-stage Extranodal NK/T-cell Lymphoma, Na…
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma [Phase 2]
Phase 2 clinical trial update for SHR-1210 in relapsed or refractory extranodal NK/T-cell lymphoma, nasal type.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: GPED Regimen for Relapsed/Refractory or Advanced ENKTCL [Phase 2]
Phase 2 trial update for GPED regimen in relapsed/refractory or advanced Extranodal NK/T-cell Lymphoma, Nasal Type.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating maintenance therapy with an anti-PD-1 antibody in extranodal NK/T-cell lymphoma, nasal type; status not specified.
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma [Phase 2]
Phase 2 trial of concomitant chemoradiotherapy with VIDL chemotherapy in extranodal NK/T-cell lymphoma, nasal type, completed with results p…
-
CLINICAL_TRIALS trial_result · 2019-01-04Clinical Trial Update: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]
Phase 2 results from a study using donor umbilical cord blood stem cell transplants in patients with hematologic malignancies have been post…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage [Phase 3]
A Phase 3 trial comparing P-Gemox versus EPOCH as first-line chemotherapy for early-stage Extranodal NK/T-cell lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma [Phase 2]
Phase 2 study evaluating pegaspargase- and methotrexate-based regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma has comp…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma [Phase 2]
Phase 2 study of GLIDE regimen followed by autologous stem cell transplantation for extranodal NK/T-cell lymphoma (nasal type) is being inve…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating radiotherapy in combination with GDP chemotherapy for stage I/II Extranodal NK/T-cell lymphoma has been completed.
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies [Phase 2]
A Phase 2 trial evaluating a combination of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with previously treated lymph…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a combination of vorinostat, rituximab, ifosfamide, carboplatin, and etoposide in adults with relapsed/refracto…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: International Extranodal NK/T-cell Lymphoma Project
The International Extranodal NK/T-cell Lymphoma Project trial sponsored by Samsung Medical Center has completed, evaluating Extranodal NK/T-…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating CAR-pNK cell immunotherapy for CD7-positive leukemias and lymphomas. The available snippet does n…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL [Phase 2]
Phase 2 study evaluating the GELOX chemotherapy regimen with concurrent radiation therapy for Stage IE/IIE Extranodal NK/T-cell lymphoma (EN…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial sponsored by the National Cancer Institute evaluated alisertib for relapsed or refractory peripheral T-cell non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for MORAb-004 in young patients with recurrent or refractory solid tumors or lymphoma; the study has been completed.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 study evaluating the combination of methoxyamine and fludarabine phosphate in adults with relapsed or refractory hematologic maligna…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma [Phase 2]
Phase 2 trial evaluating concomitant chemoradiotherapy followed by MIDLE chemotherapy for stage I/II extranodal NK/T-cell lymphoma, nasal ty…
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy [Phase 2]
Phase 2 trial update shows mild-dose IMRT after GELOX chemotherapy achieving complete tumor response in early-staged extranodal nasal-type N…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma [Phase 2]
A completed Phase 2 study evaluating the combination of bortezomib and panobinostat in relapsed or refractory peripheral T-cell lymphomas an…
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Stage I/II Nasal NK Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 trial assessing Stage I/II nasal NK/T-cell lymphoma (nasal type) was terminated; results were posted in 2014.